Program in Clinical Research, Clinical Support Services and Clinical Training
临床研究、临床支持服务和临床培训项目
基本信息
- 批准号:9550665
- 负责人:
- 金额:$ 393.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The NIEHS Clinical Research Branch has continued to expand its scope of support for clinical and translational studies. The NIEHS Clinical Research Unit (CRU) has recorded over 8000 patient encounters with over 95% patient satisfaction. Additional staff have been hired to support CRU functions. The NIEHS' CRU is integrated into the Bethesda CC via the CRIS electronic health record system and the Clinical Trials Database, and collaborated with the NIEHS Environmental Autoimmunity Group in Bethesda. Studies are currently underway at the CRU, involving the fields of asthma, cancer, cardiovascular disease, immunology, inflammation, metabolic disease, neuroendocrinology, and pharmacokinetics. Many studies take advantage of the Environmental Polymorphisms Registry (EPR), a NIEHS-operated cohort encompassing over 15,000 North Carolina residents, who have donated DNA and have agreed to be called back for phenotypic studies. EPR-related follow-up studies address issues of inflammation, DNA injury repair, endocrine receptor polymorphisms, endothelial function and lung disease. Furthermore, collaboration avenues with local universities as well as other governmental agencies are currently underway. The NIEHS Clinical Research Branch has established a comprehensive Human Research Protection Program thru the development of the Office of Human Research Compliance (OHRC). This office is responsible for managing and coordinating the pre-IRB clinical and scientific review of NIEHS clinical studies, supporting the day to day administrative operations of the IRB, Developing and maintaining electronic management systems and websites that support activities of the OHRC, Performing quality assurance/quality improvement audits of clinical sites, strengthening and enhancing the human research protection education and training program, working with scientific / clinical PIs and their staff to develop human research protocols, developing and implementing standard operational procedures, to ensure that NIEHS complies with DHHS, FDA, NIH guidelines and regulations.
NIEHS临床研究部门继续扩大其对临床和转化研究的支持范围。 NIEHS临床研究部门(CRU)记录了8000多名患者遭遇,患者满意度超过95%。 聘请了其他人员来支持CRU功能。 NIEHS的CRU通过CRIS电子健康记录系统和临床试验数据库集成到Bethesda CC中,并与贝塞斯达的NIEHS环境自动免疫集团合作。目前在CRU的研究正在进行中,涉及哮喘,癌症,心血管疾病,免疫学,炎症,代谢疾病,神经内分泌学和药代动力学的领域。 许多研究都利用了环境多态性注册表(EPR),这是一项NIEHS经营的队列,其中包括15,000多名北卡罗来纳州居民,他们已经捐赠了DNA并同意被召回进行表型研究。 EPR相关的随访研究解决了炎症,DNA损伤修复,内分泌受体多态性,内皮功能和肺部疾病的问题。 此外,目前正在与当地大学以及其他政府机构进行合作途径。 NIEHS临床研究部门通过人类研究合规办公室(OHRC)建立了一项全面的人类研究保护计划。 This office is responsible for managing and coordinating the pre-IRB clinical and scientific review of NIEHS clinical studies, supporting the day to day administrative operations of the IRB, Developing and maintaining electronic management systems and websites that support activities of the OHRC, Performing quality assurance/quality improvement audits of clinical sites, strengthening and enhancing the human research protection education and training program, working with scientific / clinical PIs and their staff to develop human research protocols,制定和实施标准操作程序,以确保NIEHS符合DHHS,FDA,NIH指南和法规。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Stavros Garantzio...的其他基金
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:77345827734582
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:95501419550141
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:85537938553793
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:1092860110928601
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:1025258910252589
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:81491138149113
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:89297998929799
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:83366498336649
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:1000073210000732
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组织损伤中的作用
- 批准号:79682527968252
- 财政年份:
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The Causal Impact of Poverty Reduction on Housing Conditions of Low-Income, U.S. Children and the Role of Housing and Neighborhood Ecosystems on Young Children's Healthy Development
减贫对美国低收入儿童住房条件的因果影响以及住房和邻里生态系统对幼儿健康发展的作用
- 批准号:1067852710678527
- 财政年份:2023
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:1067830710678307
- 财政年份:2023
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
Impact of benzene-induced MIA on fetal T cell development
苯诱导的 MIA 对胎儿 T 细胞发育的影响
- 批准号:1060588110605881
- 财政年份:2023
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
A Low-Cost Wearable Connected Health Device for Monitoring Environmental Pollution Triggers of Asthma in Communities with Health Disparities
一种低成本可穿戴互联健康设备,用于监测健康差异社区中哮喘的环境污染诱因
- 批准号:1060161510601615
- 财政年份:2023
- 资助金额:$ 393.36万$ 393.36万
- 项目类别:
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
- 批准号:1067730410677304
- 财政年份:2023
- 资助金额:$ 393.36万$ 393.36万
- 项目类别: